Drug misuse and dependency
Services
-
NDTMS: community combined review forms
Combined Review Forms (CRF) for community treatment services to use for Core Dataset P (CDS-P), from April 2020 onwards.
-
Drugs Test 1 (DT1) form
Form for the testing of specified class A drugs on persons ages 18 or over.
-
NDTMS: secure setting outcomes forms
Outcome monitoring forms for use by secure setting from April 2020 for core dataset P.
Guidance and regulation
- Controlled drugs list
- Drug misuse and dependence: UK guidelines on clinical management
- Extra funding for drug and alcohol treatment: 2022 to 2023
- NDTMS: consent and privacy notice
- ASSIST-Lite screening tool: how to use
News and communications
- Opening Speech: World Drugs Day event at Accra
- Classification and scheduling of Brorphine and Metonitazene
- Largest ever increase in funding for drug treatment
- Drug users urged to be extra careful following a high number of likely heroin overdoses
- Government consults on increasing access to lifesaving overdose medicine
Research and statistics
- ACMD Naloxone Review
- Drug misuse prevention review
- Improving Lives: Helping Workless Families indicators 2022
- Shooting Up: infections among people who inject drugs in the UK
- Substance misuse treatment in secure settings: 2020 to 2021
Policy papers and consultations
- Expanding access to naloxone
- Independent review of drugs: call for evidence, part 2
- NDTMS annual reports and methodology: proposed changes
- From harm to hope: A 10-year drugs plan to cut crime and save lives
- ACMD ageing cohort of drug users report: government response
Transparency and freedom of information releases
- Individual Placement and Support (IPS-AD) trial: privacy notice
- UK government Drug Recovery Champion annual report
- Standard Operating Procedure for using evidence in ACMD reports
- Commissioning impact on drug treatment
- Drug strategy 2016: development review